J Michael McIntosh Selected Research

Inflammasomes

1/2018

C-Reactive Protein Stimulates Nicotinic Acetylcholine Receptors to Control ATP-Mediated Monocytic Inflammasome Activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Michael McIntosh Research Topics

Disease

28	Parkinson Disease (Parkinson's Disease) 12/2015 - 01/2002
20	Neuralgia (Stump Neuralgia) 01/2024 - 11/2006
20	Pain (Aches) 01/2023 - 11/2006
14	Tobacco Use Disorder (Nicotine Dependence) 01/2016 - 02/2006
8	Inflammation (Inflammations) 01/2023 - 06/2007
8	Dyskinesias (Dyskinesia) 12/2015 - 06/2010
7	Neoplasms (Cancer) 01/2024 - 01/2013
6	Hyperalgesia 01/2024 - 11/2011
6	Chronic Pain 01/2020 - 11/2011
6	Schizophrenia (Dementia Praecox) 12/2017 - 06/2007
4	Substance-Related Disorders (Drug Abuse) 12/2022 - 02/2012
4	Acute Pain 01/2018 - 09/2012
4	Parkinsonian Disorders (Parkinsonism) 08/2013 - 06/2010
3	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 12/2015
3	Infections 01/2019 - 01/2013
3	Hypersensitivity (Allergy) 01/2016 - 09/2008
3	Nervous System Diseases (Neurological Disorders) 04/2009 - 02/2006
2	Painful Neuropathy 01/2024 - 01/2016
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2024 - 09/2012
2	Ganglion Cysts (Ganglion) 01/2021 - 06/2005
2	Paralysis (Palsy) 01/2020 - 09/2002
2	Movement Disorders (Movement Disorder) 10/2019 - 08/2009
2	Wounds and Injuries (Trauma) 01/2018 - 01/2017
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 02/2015 - 08/2012
2	Autosomal Dominant Nocturnal Frontal Lobe Epilepsy 01/2013 - 09/2007
2	Mental Disorders (Mental Disorder) 11/2012 - 12/2007
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2006 - 12/2004
1	Opioid-Related Disorders (Opiate Addiction) 04/2024
1	Cognitive Dysfunction 12/2022
1	Colorectal Neoplasms (Colorectal Cancer) 11/2022
1	Intractable Pain 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Tachycardia (Tachyarrhythmias) 01/2021
1	Heart Failure 01/2021
1	Anxiety Disorders (Anxiety Disorder) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 12/2018
1	Adenocarcinoma 12/2018
1	Carcinoma (Carcinomatosis) 08/2018
1	Multiple Trauma (Multiple Injuries) 01/2018
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2018
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2018
1	Autistic Disorder (Autism) 12/2017
1	Tourette Syndrome (Tourette's Syndrome) 12/2017
1	Epilepsy (Aura) 12/2017

Drug/Important Bio-Agent (IBA)

51	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2023 - 01/2002
31	Nicotine FDA Link 01/2016 - 08/2003
11	Analgesics (Analgesic Drugs)IBA 01/2018 - 11/2006
11	Dopamine (Intropin)FDA LinkGeneric 12/2013 - 09/2003
9	Conotoxins (Conotoxin)IBA 01/2024 - 03/2008
9	Peptides (Polypeptides)IBA 11/2022 - 08/2009
8	Levodopa (L Dopa)FDA LinkGeneric 12/2015 - 09/2003
7	LigandsIBA 01/2023 - 10/2002
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2024 - 01/2016
5	Opioid Analgesics (Opioids)IBA 01/2021 - 01/2017
4	Nicotinic AgonistsIBA 01/2018 - 10/2006
3	Cholinergic Agents (Cholinergics)IBA 01/2021 - 09/2008
3	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2021 - 06/2005
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020 - 06/2007
3	CytokinesIBA 01/2019 - 01/2018
3	Adenosine Triphosphate (ATP)IBA 12/2018 - 01/2018
2	Amyloid (Amyloid Fibrils)IBA 01/2024 - 09/2020
2	PlatinumIBA 11/2022 - 01/2016
2	Therapeutic UsesIBA 01/2021 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 09/2020 - 01/2013
2	3- (5,6- dichloropyridin- 3- yl)- 3,6- diazabicyclo(3.2.0)heptaneIBA 12/2015 - 04/2014
2	VenomsIBA 10/2014 - 09/2002
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 02/2013 - 07/2007
2	Formaldehyde (Formol)FDA Link 09/2012 - 11/2011
2	Varenicline (Chantix)FDA Link 09/2012 - 08/2012
2	Antipsychotic Agents (Antipsychotics)IBA 03/2012 - 12/2007
2	MecamylamineIBA 06/2010 - 09/2007
2	alpha-conotoxin MIIIBA 06/2007 - 12/2004
1	AlkaloidsIBA 04/2024
1	coronardineIBA 04/2024
1	Conus generalis alpha-conotoxinIBA 01/2024
1	Antineoplastic Agents (Antineoplastics)IBA 11/2022
1	DisulfidesIBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2021
1	Midazolam (Versed)FDA LinkGeneric 01/2021
1	Mollusk VenomsIBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2019
1	ethyleneIBA 12/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2018
1	LipopolysaccharidesIBA 08/2018
1	C-Reactive ProteinIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	InterleukinsIBA 01/2018
1	InflammasomesIBA 01/2018
1	Interleukin-18 (Interleukin 18)IBA 01/2018
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2018
1	Streptozocin (Streptozotocin)FDA Link 01/2018

Therapy/Procedure

19	Therapeutics 01/2022 - 01/2002
8	Drug Therapy (Chemotherapy) 01/2024 - 09/2012
2	Ligation 01/2018 - 09/2008
2	Analgesia 01/2015 - 09/2012
1	Aftercare (After-Treatment) 11/2022
1	Extracorporeal Membrane Oxygenation 01/2021
1	Injections 01/2020